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Objectives: This is a prospective study of the clinical efficacy of the V.A.C. Granufoam Bridge Dressing for the
treatment of diabetic foot ulcers.
Materials and methods: Five consecutive patients with diabetic foot ulcers were treated with V.A.C.
Granufoam Bridge Dressings and studied over a period of 2248 days. The indications for treatment included
diabetic patients with open ray amputation wounds and wounds post-drainage for abscess with exposed deep
structures. Clinical outcome was measured in terms of reduction in wound dimensions, presence of wound
granulation, microbial clearance, and development of wound complications.
Results: Our results showed that with V.A.C. therapy, wound healing occurred in all patients. The number of
dressings required ranged from 8 to 10. The baseline average wound size was 23.1 cm
2. Wound areas shrunk
by 18.441.7%. All subjects achieved 100% wound bed granulation with an average length of treatment of 33
days. Microbial clearance was achieved in all cases. All wounds healed by secondary intention in one case and
four cases required split-thickness skin grafting.
Conclusion: The V.A.C. Granufoam Bridge Dressing is effective in the treatment of diabetic foot ulcers. It
promotes reduction of wound area, wound bed granulation, and microbial clearance. By allowing placement
of the suction pad outside the foot, it allowed patients to wear protective shoes and to walk non-weight
bearing with crutches during V.A.C. therapy.
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F
oot ulcers affect 1025% of diabetic patients (1).
Management of a diabetic foot ulcer is often a
challenging problem. Healing of these ulcers often
takes a long time and may need one or more debride-
ments. The treatment of such ulcers, therefore, needs time
with a prolonged hospital stay, intensive wound manage-
ment, and high hospitalization costs.
Large ulcers that do not heal adequately by secondary
intention usually require split-thickness skin grafting for
skin cover. However, the successful healing of such
wounds depends mainly on the quality of wound bed
preparation in promoting good granulation tissue.
Over the years several advanced wound care products
have been developed, all with the aim of achieving wound
bed optimization for eventual wound closure. In parti-
cular, negative pressure wound therapy (NPWT) using
the Vacuum Assisted Closure (V.A.C.) Therapy System
(Kinetic Concepts Inc, San Antonio, TX, USA) has
gained increasing popularity for the treatment of chronic
and complex wounds. The NPWT has been shown to
accelerate wound healing by reducing local tissue edema,
promoting granulation tissue formation, increasing local
blood flow, and decreasing bacterial bioburden in both
animal and clinical studies (2, 3). The efficacy of V.A.C.
dressings has been demonstrated in several randomized
controlled studies, which have shown significantly faster
wound healing rates compared to conventional moist
wound therapy (46).
V.A.C. therapy has been found to be useful for
treatment of traumatic wounds, diabetic wounds (5, 7),
pressure ulcers, and venous ulcers. As an extension to
V.A.C. therapy, the Granufoam Bridge Dressing has been
designed to allow patients to wear protective shoes and to
allow early mobility with walking non-weight bearing
with a pair of crutches. It also allows off-loading devices
to be applied simultaneously.
This prospective study evaluates the efficiency of
V.A.C. Granufoam Bridge Dressing in promoting wound
bed granulation and wound closure for diabetic foot
ulcers.
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A prospective case series of five consecutive patients was
conducted by the National University Hospital, Singa-
pore over a period of 2248 days. The study population
was made up of four male subjects and one female subject
with a mean age of 58.8 years (range, 5164 years).
Inclusion criteria into this study consisted of open ray
amputation wounds (three patients) and wounds post-
drainage for abscess with exposure of deep structures
such as tendon and fascia (two patients). Patients with
previous V.A.C. therapy and those on other forms of
advanced wound therapy like hyperbaric oxygen therapy,
normothermic wound therapy, or growth factor therapy
within 30 days of the study start date were excluded.
Patients on corticosteroids, immunosuppressive agents,
or chemotherapeutic agents and patients with poorly
controlled medical problems were also excluded from the
study.
The NPWT delivered by the V.A.C. Granufoam Bridge
Dressing system consisted of the open cell polyurethane
foam dressing, negative pressure generating unit with an
attached disposable canister, and an encapsulated bridge
dressing with an integrated suction pad that transmitted
the negative pressure to the wound (Fig. 1). The V.A.C.
dressings were applied by the medical officer intra-
operatively during the debridement operation and post-
operatively by trained staff nurses strictly according to
the manufacturer’s guidelines and a continuous pressure
of 125 mmHg was delivered to all wounds. Change of
dressing was performed every 4872 hours and wound
inspection was done at every dressing change. The
wounds were examined for degree of granulation, reduc-
tion in size of the wound, and development of wound
complications such as infection, tissue necrosis, and skin
maceration. The reduction in the size of the wound was
measured by placing two pieces of transparent plastic
sheets directly on the wound and marking the outline of
the ulcer with a permanent ink marker on the outer sheet.
The inner plastic sheet was discarded. The outer plastic
sheet with the ulcer outlined on it was placed over a
calibrated graph paper. The area of the ulcer was then
measured in square centimeters to the nearest square
millimeter.
In all patients, the suction pad was applied on the
lateral side of the leg proximally (Fig. 2). This allowed the
patient, after application of the dressing on the foot, to
wear protective shoes. All patients were allowed to
mobilize early and walk non-weight bearing using a
pair of crutches during the whole period of V.A.C.
therapy. None of our patients had a neuropathic ulcer
in the sole of the foot due to Charcot joint disease. No
off-loading device was therefore needed in all patients.
The clinical endpoints of the study were complete ulcer
healing by secondary intention and adequate optimiza-
tion of wound bed permitting skin grafting (sufficient
reduction in ulcer size, adequate wound granulation, and
eradication of wound bed bacterial bioburden).
Results
Table 1 summarizes the demographics and pre-treatment
assessment of the study subjects. Three patients had
reasonably well-controlled blood sugar levels with a
HbA1c ranging from 6.7 to 8.7%; two had poorly
controlled diabetes with HbA1c of 11.1 and 15.0% due
to poor compliance to medications, but were subse-
quently counseled by the diabetic nurse educator and
had their blood sugar levels optimized during their
treatment period. Other significant co-morbidities in-
clude ischemic heart disease in two patients and end-stage
renal failure requiring hemodialysis in one patient. All
medical co-morbidities were well controlled throughout
the duration of the study.
Table 1 showed that all the markers of infection were
raised due to the infection present when the patients were
first seen. Following V.A.C. therapy, all the markers have
returned to normal showing that in all cases the infection
Fig. 1. (a) Suction pad, (b) polyurethane foam dressing, and (c)
encapsulated bridge dressing.
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Methicillin-sensitive Staphylococcus aureus in four cases
and Methicillin-resistant Staphylococcus aureus in one
case. All had polymicrobial infection indicating the
presence of a severe infection, two patients having three
organisms and another two patients having two organ-
isms in the wound. All wound swabs taken after V.A.C.
therapy was completed and indicated negative cultures.
The wounds in our study had a mean chronicity of 23.2
days (range, 760 days). Surgical debridement to remove
all infected and necrotic tissue was performed prior to
V.A.C. application to all wounds. Two patients underwent
single ray amputations, two patients underwent abscess
drainage and wound debridement, and one patient
underwent three surgeries (first ray amputation, first
ray amputation stump debridement, second ray excision
arthroplasty) before starting on the V.A.C. therapy
(Table 2).
Overall there was a reduction in the wound sizes of all
five patients recruited into the study (Figs 3 and 4). One
patient had complete ulcer closure by secondary intention
with 100% re-epithelialization after duration of 42 days
during which 10 V.A.C. dressings were applied. The
average size of the wounds at the start of the study was
Fig. 2. Application of V.A.C. bridge dressing.
Table 1. Patient demographics, wound diagnosis and grading, infection markers, and wound cultures
Infection markers
(on arrival)
Infection markers
(after V.A.C.)
No.
Age
(y) Gender
HbA1c
(%) Wound diagnosis
Wagner
grade WBC CRP ESR WBC CRP ESR
Wound swab
(before V.A.C.)
Wound
swab (after
V.A.C.)
1 56 Male 7.1 Left second toe
wet gangrene
3 17.35 67 121 9.40 18 25 Methicillin-sensitive
Staphylococcus aureus,
Group B Streptococcus
Negative
2 60 Male 6.7 Right heel abscess
and cellulitis
3 15.43 63 98 6.25 12 35 Methicillin-sensitive
Staphylococcus aureus,
Peptostreptococcus
Negative
3 63 Male 8.7 Left first toe wet
gangrene
3 20.19 83 55 9.56 16 22 Methicillin-resistant
Staphylococcus aureus
Negative
4 64 Male 11.1 Right foot dorsum
abscess and
cellulitis
3 20.49 125 65 8.80 19 18 Methicillin-sensitive
Staphylococcus aureus
Negative
5 51 Female 15.0 Left second toe
wet gangrene
3 19.53 55 132 8.56 12 15 Methicillin-sensitive
Staphylococcus aureus
Negative
Abbreviations: CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; WBC: white blood cell.
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(page number not for citation purpose)Fig. 3. (a) First ray amputation wound, day 1 post-operatively; and (b) wound appearance prior to split thickness skin grafting, day 34
post-operatively (after 10 V.A.C. dressings).
Table 2. V.A.C. therapy duration, change of dressings, number of surgical debridements, and time to complete microbial clearance
No.
Length of
treatment (days)
No. of V.A.C.
dressings used
No. of surgical
debridements
Time to complete
microbial
clearance (days) Surgical procedures done
1 22 8 1 20 Left foot second ray amputation
2 42 10 1 38 Right heel abscess drainage and
wound debridement
3 34 10 3 31 1. Left foot first ray amputation
2. Left foot first ray amputation
stump wound debridement
3. Left foot second ray excision
arthroplasty
4 48 9 1 45 Right foot dorsum abscess drainage
and wound debridement
5 31 9 1 29 Left foot second ray amputation
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2 (range, 9.835.8 cm
2), and by the end of the
study the average wound size had reduced to 15.1 cm
2
(range, 6.323.0 cm
2). The mean percentage reduction in
wound size was 32.8% (range, 18.441.7%). Table 3
clearly illustrates the progression of the wound areas for
each of the five patients.
In addition to wound areas, all wounds were also
clinically assessed for development of wound granulation
and secondary wound complications. All five patients
started showing signs of wound granulation within 4 to
8 days of starting V.A.C. therapy and all eventually
achieved 100% wound granulation over a period of
Fig. 4. (a) Second ray amputation wound, day 1 post-operatively; and (b) wound appearance prior to split thickness skin grafting, day
22 post-operatively (after eight V.A.C. dressings).
Table 3. Wound progression and ﬁnal outcome
Wound area (cm2)
Change in wound
area
No.
After final
surgical
debridement
End of
study
Actual
(cm
2)
Percentage
(%)
Time taken for
appearance of
granulation tissue
(days)
Time taken for
50% granulation
(days)
Time taken for
100% granulation
(days) Final outcome
1 30 17.5 12.5 41.7 4 9 20 split thickness skin grafting
2 10 6.3 3.7 37.0 5 15 42 Secondary
intention
3 35.8 23 12.8 35.8 6 13 30 split thickness skin grafting
4 29.8 20.5 9.3 31.2 8 19 45 split thickness skin grafting
5 9.8 8 1.8 18.4 5 13 28 split thickness skin grafting
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sion of wound areas and wound granulation of the five
patients over the study period. None of the wounds
developed frank clinical infection during the course of the
treatment. There was no purulent discharge or wound
bed necrosis in any of the wounds. All slough and biofilm
that had accumulated in the wounds during V.A.C.
treatment was thoroughly debrided in the ward prior to
the application of the next V.A.C. dressing.
Wound swabs were also taken weekly for culture and
sensitivity testing, and antibiotics adjusted accordingly.
Initial wound swab growths are detailed in Table 1, but
wound swabs of all five patients had no bacterial growth
by the end of the study (i.e. at the point of skin grafting
or complete re-epithelialization). The mean time to
complete microbial clearance from the wounds was 32.6
days (range, 2045 days).
In all five cases, no complication was seen at the site of
the bridge dressing.
Discussion
This is the first study in Singapore evaluating the
effectiveness of the V.A.C. Granufoam Bridge Dressing
in the treatment of diabetic foot ulcers. The ability of
regular V.A.C. dressings in promoting wound bed gran-
ulation and healing has been demonstrated in several
studies (48), including one that was recently published
by the first author of this paper (7). Wound bed
optimization is crucial in preventing wound complica-
tions that may lead to higher amputations and for
eventual wound closure by secondary intention or split
skin grafting.
The V.A.C. Granufoam Bridge Dressing in our study
showed comparable wound reduction capabilities as the
regular V.A.C. dressings with an average wound size
reduction of 32.8%. A randomized controlled crossover
trial by Eginton et al. (8) achieved an average 59% wound
volume reduction in patients on V.A.C. dressings, which
was significantly greater than the 0.1% wound volume
reduction achieved by moist wound gauze dressings,
while Nather et al. (7) saw a mean wound area reduction
of 24.9% in a local prospective case series on 11 patients.
Rate of wound granulation in our study was also
comparable to that of published literature. Two large
multicentric, randomized controlled trials conducted by
Armstrong et al. (4) and Blume et al. (5) reported a
median time of 42 days and 56 days, respectively, for 76
100% wound bed granulation using V.A.C. dressings for
average wound sizes of 22.3 cm
2 and 13.5 cm
2, respec-
tively, both of which were significantly faster than that for
wounds treated by conventional moist wound therapy.
The baseline average wound size in our study was 23.1
cm
2 and 100% wound bed granulation was achieved in all
five of our study subjects with a median time to 100%
granulation of 30 days.
Careful patient selection and meticulous wound bed
preparation prior to V.A.C. application is crucial in
ensuring good clinical outcome. Patients with untreated
underlying wound infections and osteomyelitis were
excluded from the study. All wounds were thoroughly
debrided of infected and necrotic tissue before V.A.C.
application. Nather et al. (7) showed the V.A.C. dressing
to be effective for ray amputation wounds, wounds post-
debridement for necrotizing fasciitis, and wounds for
post-drainage for abscess with exposed deep structure
such as tendon and fascia, although such ulcers can also
be treated by conventional dressings. A proper rando-
mized control study was needed to show whether V.A.C.
dressings were significantly better than conventional
dressings. In this paper, our indications include three
ray amputation wounds and two post-drainage wounds
for an abscess with exposed deep structure.
The main advantage of a Bridge V.A.C. Dressing is the
ability to position the suction pad outside the foot or
weight bearing area of the foot. In our patients the pad
was applied on the lateral side of the calf. The application
of the pad far away from the wound site has the benefit of
preventing skin maceration around the wound. This
complication can develop when the suction pad is applied
directly over the wound. The other benefit is that the
Bridge V.A.C. Dressing allows protective footwear to be
worn after the V.A.C. application so that the patients can
be mobilized early and walk non-weight bearing in the
ward using a pair of clutches. All our patients were
allowed to ambulate on the second post-operative day.
The additional advantage of a Bridge V.A.C. Dressing is
to allow off-loading devices to be applied simultaneously
with the V.A.C. dressing. However, we were unable to
experience this benefit as none of our cases were
neuropathic sole ulcer due to Charcot joint disease to
require off-loading treatment.
In the past when regular V.A.C. dressings were used for
treating diabetic foot ulcers, we had on several occasions
(three cases) improvised by positioning the suction pad
outside the foot by creating bridges using additional
material to allow patients to wear protective shoes and
walk during the V.A.C. therapy. However, with the
availability of a Bridge V.A.C. Dressing, this is no longer
necessary. The use of the new custom-made dressing is
not only convenient and saves time but also reduces
wastage of resources. The new bridge dressing is designed
for better function though it may cost slightly more.
The adding of a bridge in the new V.A.C. is not
harmful and is not likely to cause any complication. It is
possible that in some cases if the bridge is improperly
bandaged to the leg (too tight), the suction may not
function. Care must be taken to ensure that no unduly
high pressure is applied anywhere along the bridge and
also that the bridge must not have any kink.
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V.A.C. Granufoam Bridge Dressing for the treatment of
diabetic foot ulcers. We found the bridge dressing to be
effective in promoting reduction of the wound size,
wound bed granulation, as well as microbial clearance.
Wound healing was successful in all five cases  one by
secondary intention and four by split-thickness skin
grafting.
Whilst our study of five cases showed the V.A.C.
dressing to be effective in treatment of diabetic foot
ulcers, a randomized controlled trial with a larger cohort
of patients is needed to better establish the safety and
efficacy of profile of this new bridge V.A.C. dressing.
Patients treated by the bridge V.A.C. dressing could then
be compared with diabetic ulcers treated by current
conventional dressings (controls).
Conclusion
The new V.A.C. Granufoam Bridge Dressing was found
to be effective in the treatment of diabetic foot ulcers. It
promotes wound area reduction, wound bed granulation,
and achieves microbial clearance. The placement of the
suction pad outside the foot allowed the patients to wear
protective shoes and to walk non-weight bearing with
crutches during the V.A.C. therapy.
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